Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
AMPRONIX
SCHILLER AG

Screening Mammography for Most Women Recommended Every Two Years

By Medimaging International staff writers
Posted on 17 Feb 2014
Implementation of new guidelines recommending screening mammography every two years for women aged 50 to 74 years would result in breast cancer screening that is just as effective, while saving the United States USD 4.3 billion yearly in healthcare costs, according to new data. The study compared three possible mammography-screening approaches with a model of current US screening practices.

The study’s findings were published on February 4, 2014, in the journal Annals of Internal Medicine. The study’s investigators recommend adoption of guidelines developed in 2009 by the US Preventive Services Task Force (USPSTF; Rockville, MD, USA). Under those guidelines, in addition to biennial screening for women aged 50 to 74, women aged 40 to 49 would be screened according to other risk factors, and women 75 and older would be screened depending on the presence or absence of other diseases.

The study was led by Laura J. Esserman, MD, MBA, a professor of surgery and radiology from the University of California, San Francisco (UCSF; USA), and an internationally known leader in the field of breast cancer. “The USPSTF guidelines are based on the best scientific evidence to date,” said Dr. Esserman, director of the Carol Franc Buck Breast Care Center at the UCSF Helen Diller Family Comprehensive Cancer Care Center. “What we need now is a better way to assess breast cancer risk and implement a more risk-based approach to screening. We have demonstrated that the resources for doing this are already in the system. We should redirect them to learning, enabling change, and improving outcomes.”

Approximately 70% of women in the United States, according to the investigators’ estimate, were screened for breast cancer in 2010, at a cost of USD 7.8 billion. Some women are screened yearly, some biennially, and some are screened on a sporadic basis.

The scientists compared this current outlook of breast cancer screening with three simulated models: annual screening of 85% of women aged 40 to 84, in accordance with recommendations from the American Cancer Society and many other policymaking organizations, at a yearly estimated cost of USD 10.1 billion; biennial screening of 85% of women aged 50 to 70, comparable to guidelines used in many European countries, at a yearly estimated cost of USD 2.6 billion; and screening in accordance with USPSTF recommendations, which the authors estimate would cost USD 3.5 billion per year at a screening rate of 85%.

“Over the last decade, in study after study, it has become very clear that—apart from limited, specific high risk groups—biennial screening is as effective as annual screening mammography,” said Dr. Esserman. “At the same time, annual screening is associated with a greater likelihood of false-positive results, which have an adverse impact on women’s well-being and quality of life. From the viewpoint of women’s health, the USPSTF screening recommendations make sense. “We can go one step further and learn who is at risk for what kind of breast cancer, and over time, further tailor screening by adjusting the age to start and frequency as well as include recommendations for prevention.”

Lead author Cristina O'Donoghue, MD, currently at the University of Illinois at Chicago (IL, USA), but with UCSF at the time of the study, noted that the billions of dollars saved from avoiding less-effective mammography screening could be used to improve women’s health. “We could increase women’s participation in screening, improve routine assessment of breast cancer risk and referral services for women at high risk, offer better genetic counseling for women with a family history of breast cancer and work on improving the quality of screening, with an emphasis on higher-quality mammography read by specialized mammographers,” said Dr. O'Donoghue. “These would be only some of the potential benefits of using our healthcare resources more intelligently.”

Related Links:

University of California, San Francisco
US Preventive Services Task Force



SuperSonic Imagine
RADCAL
RTI ELECTRONICS AB

Channels

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.